Changing trends in well differentiated thyroid carcinoma over eight decades

被引:35
|
作者
Nixon, Iain J. [1 ]
Ganly, Ian [1 ]
Patel, Snehal G. [1 ]
Palmer, Frank L. [1 ]
Whitcher, Monica M. [1 ]
Ghossein, Rony [2 ]
Tuttle, R. Michael [3 ]
Shaha, Ashok R. [1 ]
Shah, Jatin P. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Head & Neck Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Endocrinol, New York, NY 10021 USA
关键词
Thyroid; Cancer; Well differentiated; Papillary thyroid cancer; Follicular thyroid cancer; Hurthle cell thyroid cancer; PROGNOSTIC-FACTORS; UNITED-STATES; INCREASING INCIDENCE; PAPILLARY CARCINOMA; RISK GROUPS; CANCER; MANAGEMENT; THERAPY; SURGERY;
D O I
10.1016/j.ijsu.2012.10.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: The incidence of well differentiated thyroid cancer (WDTC) is rising in the USA. The objective of this study is to present the changes in incidence, presentation, management and outcomes of WDTC within our institution over the past 8 decades. Methods: 2797 patients managed between 1932 and 2005 at Memorial Sloan Kettering Cancer Center were identified from our institutional database. Results: There has been an increase in the number of patients managed per decade. Although the median age was 45 years, patients managed post-1985 were more likely to be over 45 years (53% versus 44%, p < 0.001). The percentage of women increased from 68% to 72% (p = 0.026), and the percentage of papillary carcinomas also increased, from 78% to 92%, p < 0.001. An increase in early stage tumors was observed with pT1 lesions increasing from 19% to 48%. Patients in the latter cohort were less likely to have thyroid lobectomy (29% versus 72%, p < 0.001). There was a significant change in the use of RRA, with 8% of the early versus 44% of the latter group receiving post-operative RRA (p < 0.001). Since the introduction of risk group stratification disease specific survival (DSS) has not changed significantly. With a median follow up of 90 months, 10 year DSS rates were below 90% in the cohort managed prior to the 1970s, which rose to >95% thereafter (p < 0.001). Conclusions: Older patients with earlier stage disease present an increasing workload for surgical oncologists. Excellent outcomes remain unchanged despite increasingly aggressive surgical and medical management. (C) 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:618 / 623
页数:6
相关论文
共 50 条
  • [1] Changing trends in the management of well-differentiated thyroid carcinoma in Korea
    Lee, Yong Sang
    Chang, Hang-Seok
    Park, Cheong Soo
    [J]. ENDOCRINE JOURNAL, 2016, 63 (06) : 515 - 521
  • [2] Current trends in the management of well differentiated papillary thyroid carcinoma
    Solomon, BL
    Wartofsky, L
    Burman, KD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (01): : 333 - 339
  • [3] Trends in ecology and conservation over eight decades
    Anderson, Sean C.
    Elsen, Paul R.
    Hughes, Brent B.
    Tonietto, Rebecca K.
    Bletz, Molly C.
    Gill, David A.
    Holgerson, Meredith A.
    Kuebbing, Sara E.
    McDonough MacKenzie, Caitlin
    Meek, Mariah H.
    Verissimo, Diogo
    [J]. FRONTIERS IN ECOLOGY AND THE ENVIRONMENT, 2021, 19 (05) : 274 - 282
  • [4] Well-differentiated carcinoma of the thyroid
    Boone, RT
    Fan, CY
    Hanna, EY
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2003, 36 (01) : 73 - +
  • [5] Well-differentiated thyroid carcinoma
    Segal, K
    Raveh, E
    Lubin, E
    Abraham, A
    Shvero, J
    Feinmesser, R
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1996, 17 (06) : 401 - 406
  • [6] Recurrent well-differentiated thyroid carcinoma
    Magarey, Matthew J. R.
    Freeman, Jeremy L.
    [J]. ORAL ONCOLOGY, 2013, 49 (07) : 689 - 694
  • [7] Well Differentiated Thyroid Carcinoma: Current Treatment
    J. Kenneth Byrd
    Robert J. Yawn
    Christina S. T. Wilhoit
    Nicoleta D. Sora
    Linda Meyers
    Jyotika Fernandes
    Terry Day
    [J]. Current Treatment Options in Oncology, 2012, 13 : 47 - 57
  • [8] Well Differentiated Thyroid Carcinoma: Current Treatment
    Byrd, J. Kenneth
    Yawn, Robert J.
    Wilhoit, Christina S. T.
    Sora, Nicoleta D.
    Meyers, Linda
    Fernandes, Jyotika
    Day, Terry
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 47 - 57
  • [9] EFFECTIVENESS OF TREATMENT OF WELL DIFFERENTIATED THYROID CARCINOMA
    BUCKWALTER, J
    MADARAS, JS
    MASON, EE
    SOPER, RT
    [J]. SURGERY GYNECOLOGY & OBSTETRICS, 1961, 113 (04): : 427 - &
  • [10] APPROACH TO WELL DIFFERENTIATED THYROID-CARCINOMA
    MUSAFIJA, A
    KOCIC, D
    [J]. PERIODICUM BIOLOGORUM, 1990, 91 (04) : 479 - 480